Opendata, web and dolomites
Horizon2020 projects coordinated by "INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES"
| # | ||||
|---|---|---|---|---|
| 1 | TREGENERATION Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes | 2015 | 5˙899˙250.00 | 5˙899˙250.00 |
| 2 | INPACT Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication. | 2015 | 1˙390˙500.00 | 850˙500.00 |
| 3 | EXCELLTOINNOV Leverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection. | 2015 | 2˙777˙183.00 | 2˙499˙465.00 |
| 4 | DEVOTED_MIR MicroRNA determinants of the balance between effector and regulatory T cells in vivo | 2015 | 2˙000˙000.00 | 2˙000˙000.00 |
| 5 | IL7SIGNETURE IL-7/IL-7R signaling networks in health and malignancy | 2015 | 1˙988˙125.00 | 1˙988˙125.00 |
| 6 | PROTEINCONJUGATES A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates | 2015 | 2˙542˙771.00 | 2˙542˙770.00 |
| 7 | TWINNTOINFECT Unleash IMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation | 2016 | 1˙000˙000.00 | 1˙000˙000.00 |
| 8 | RETUBI Towards outstanding research and training in tumour biology at IMM | 2016 | 999˙975.00 | 999˙975.00 |
| 9 | SYNANET Neurologic and Psychiatric Disorders: from synapses to networks | 2016 | 999˙996.00 | 999˙996.00 |
| 10 | SYNAPTICMITOCHONDRIA Quality Control and Maintenance of Synaptic Mitochondria | 2016 | 1˙300˙000.00 | 1˙300˙000.00 |
| 11 | AXIAL.EC PRINCIPLES OF AXIAL POLARITY-DRIVEN VASCULAR PATTERNING | 2016 | 1˙618˙750.00 | 1˙618˙750.00 |
| 12 | MUSCLEGUY A novel muscle disorders 3D in vitro system for drug screening and validation. | 2016 | 150˙000.00 | 150˙000.00 |
| 13 | LDC4PCATHER BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 | 160˙635.00 | 160˙635.00 |
| 14 | REUSE4MALARIA Drug Repurposing for Malaria Chemoprotection | 2016 | 145˙500.00 | 145˙500.00 |
| 15 | LYSOMOD Genetic and Small Molecule Modifiers of Lysosomal Function | 2017 | 1˙156˙500.00 | 1˙102˙500.00 |
| 16 | TRPLIGDRUGCONJ TRPV1-targeted ligand-drug conjugates to treat prostate cancer | 2017 | 160˙635.00 | 160˙635.00 |
| 17 | FATTRYP Exploring the hidden life of African trypanosomes: parasite fat tropism and implications for disease | 2018 | 2˙000˙000.00 | 2˙000˙000.00 |
| 18 | DEVOSIGNGAMMADELTA Tracking γδ T cell development and TCRγδ proximal signalling | 2018 | 160˙635.00 | 160˙635.00 |
| 19 | ACORN Nanoparticle-Based Therapeutic Applications and Detection of Carbon Monoxide Releasing Molecules | 2018 | 1˙000˙000.00 | 1˙000˙000.00 |
| 20 | MYOCHIP Building a 3D innervated and irrigated muscle on a chip. | 2018 | 3˙153˙553.00 | 3˙153˙553.00 |
| 21 | VECARE Selective retention of VEGF for cancer and retinopathies therapeutics | 2019 | 150˙000.00 | 150˙000.00 |
| 22 | RIBOMED RNA in disease | 2019 | 799˙750.00 | 799˙750.00 |
| 23 | NOVIRUSES2BRAIN ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals | 2019 | 3˙933˙965.00 | 3˙933˙965.00 |
| 24 | ADAPT2FLOW Adaptive and maladaptive endothelial cell dynamics during blood flow-driven vascular patterning | 2019 | 147˙815.00 | 147˙815.00 |
| 25 | SIMICA Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs) | 2019 | 800˙000.00 | 800˙000.00 |
| 26 | TRYPTISSUE Characterising Trypanosoma tissue tropism: new perspectives for variant surface glycoproteins | 2019 | 159˙815.00 | 159˙815.00 |
| 27 | IL7RSIGNATHER Antibody-based IL-7R targeted therapies | 2020 | 0.00 | 150˙000.00 |
| 28 | GELGENECIRCUIT Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits. | 2020 | 1˙435˙312.00 | 1˙435˙312.00 |
| 29 | CLICKANDTREATCANCER Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer | 2020 | 159˙815.00 | 159˙815.00 |
| 30 | SENATOR Staff Exchange for Novel applications in 19f magnetic resonance imaging | 2020 | 1˙541˙000.00 | 1˙541˙000.00 |
| 31 | EVOLSPLICEKINETICS From co-transcriptional splicing kinetics to the evolutionary impact of exon and intron definition | 2020 | 147˙815.00 | 147˙815.00 |
More Horizon 2020 projects
The Institution INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES has been involved also in the following Horizon 2020 projects.